Literature DB >> 10211911

Psychomotor performance of long-term benzodiazepine users before, during, and after benzodiazepine discontinuation.

K Rickels1, I Lucki, E Schweizer, F García-España, W G Case.   

Abstract

Long-term (mean, 8 years) users of benzodiazepines (BZs) were administered a small battery of cognitive tests on three occasions (before BZ taper, and 5 and 12 weeks post taper) as part of their BZ discontinuation program. Ninety-six patients had 5-week and 77 patients had 12-week data. For taper successes, BZ-free status was confirmed by weekly BZ plasma level determinations. Age and education, as well as baseline test scores, were used as covariates for all data analyses. Patients who successfully tapered off BZ were able to complete symbol copying (SC) and digit symbol substitution (DSST) tasks faster than patients still taking BZ (p < 0.05). In addition, using an adjective check list, patients with taper success, i.e., BZ-free patients, reported lower levels of mental and physical sedation and higher levels of tranquilization (p < 0.05) than did patients still taking BZ. These results were confirmed in two multiple regression analyses with SC and DSST as the dependent variables. Higher baseline, younger age, and successful taper status (off BZ) were selected as significant independent predictors of SC and DSST scores. In summary, cognitive functions improved for many long-term BZ users after discontinuing their BZ intake.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10211911     DOI: 10.1097/00004714-199904000-00003

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  10 in total

1.  Tapering off benzodiazepines in long-term users: an economic evaluation.

Authors:  Richard C Oude Voshaar; Paul F M Krabbe; Wim J M J Gorgels; Eddy M M Adang; Anton J L M van Balkom; Eloy H van de Lisdonk; Frans G Zitman
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  Cognitive effects of long-term benzodiazepine use: a meta-analysis.

Authors:  Melinda J Barker; Kenneth M Greenwood; Martin Jackson; Simon F Crowe
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

3.  Psychomotor and anxiolytic effects of mexazolam in patients with generalised anxiety disorder.

Authors:  Luís Ferreira; Maria-Luísa Figueira; Alberto Bessa-Peixoto; António Marieiro; Rodolfo Albuquerque; Cristina Paz; Ana Cerqueira; Pedro Damião; Ana Dolgner; Jasper Dingemanse
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

4.  Adverse performance effects of acute lorazepam administration in elderly long-term users: pharmacokinetic and clinical predictors.

Authors:  Nunzio Pomara; Sang Han Lee; Davide Bruno; Timothy Silber; David J Greenblatt; Eva Petkova; John J Sidtis
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-09-06       Impact factor: 5.067

5.  Benzodiazepine use among adults residing in the urban settlements of Karachi, Pakistan: a cross sectional study.

Authors:  Saleem P Iqbal; Syed Ahmer; Salima Farooq; Yasmin Parpio; Ambreen Tharani; Rashid A M Khan; Mohammad Zaman
Journal:  Subst Abuse Treat Prev Policy       Date:  2011-08-01

6.  Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABA(A) Receptor Modulators?

Authors:  Christiaan H Vinkers; Berend Olivier
Journal:  Adv Pharmacol Sci       Date:  2012-03-29

Review 7.  Prescription Sedative Misuse and Abuse.

Authors:  Michael F Weaver
Journal:  Yale J Biol Med       Date:  2015-09-03

8.  Do drug treatment variables predict cognitive performance in multidrug-treated opioid-dependent patients? A regression analysis study.

Authors:  Pekka Rapeli; Carola Fabritius; Hely Kalska; Hannu Alho
Journal:  Subst Abuse Treat Prev Policy       Date:  2012-11-02

9.  Prescription patterns of benzodiazepines in the Lebanese adult population: a cross-sectional study.

Authors:  Wijdan H Ramadan; Ghada M El Khoury; Mary E Deeb; Marwan Sheikh-Taha
Journal:  Neuropsychiatr Dis Treat       Date:  2016-09-06       Impact factor: 2.570

Review 10.  Is Long-Term Benzodiazepine Use a Risk Factor for Cognitive Decline? Results of a Systematic Review.

Authors:  Danilo Nader; Linda Gowing
Journal:  J Addict       Date:  2020-01-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.